Incidence and prediction of major cardiovascular complications in head and neck surgery

Head and Neck

Volumn 32, Issue 11, 2010, Pages 1485-1493

  Datema, Frank R ^a   Poldermans, Don ^a   Baatenburg De Jong, Robert J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

cardiovascular; comorbidity; complications; head and neck surgery; risk assessment

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CALCULATION; CANCER MORTALITY; CAUSE OF DEATH; COMORBIDITY; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; HEAD AND NECK SURGERY; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; MEDICAL SOCIETY; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; POSTOPERATIVE COMPLICATION; PREDICTION; PRESCRIPTION; PRIMARY SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY; PRIMARY SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FREE TISSUE FLAPS; HEAD AND NECK NEOPLASMS; HEART DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LENGTH OF STAY; MALE; MIDDLE AGED; NECK DISSECTION; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 78649461435     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21351     Document Type: Article

References (19)

1. Piccirillo JF, Lacy PD, Basu A, Spitznagel L,. Development of a new head and neck cancer-specific comorbidity index. Arch Otolaryngol Head Neck Surg 2002; 128: 1172-1179.
2. Piccirillo JF, Costas I,. The impact of comorbidity on outcomes. ORL 2004; 66: 180-185.
3. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL,. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004; 291: 2441-2447.
4. Ferrier MB, Spuesens EB, Le Cessie S, Baatenburg de Jong RJ,. Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg 2005; 131: 27-32.
5. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-1049.
6. Boersma E, Kertai MD, Schouten O, et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 2005; 118: 1134-1141.
7. Burgers JS, Simoons ML, Hoes AW, Stehouwer CDA, Stalman WAB,. Richtlijn "cardiovasculair risicomanagement." Ned Tijdschr Geneeskd 2007; 151: 1068-1074.
8. Boersma E, Poldermans D,. ß-Blockers in non-cardiac surgery: haemodynamic data needed. Lancet 2008; 372: 1930-1932.
9. Farwell DG, Reilly DF, Weymuller EA, Greenberg DL, Staiger TO, Futaran NA,. Predictors of perioperative complications in head and neck patients. Arch Otolaryngol Head Neck Surg 2002; 125: 505-511.
10. Clark JR, McCluskey SA, Hall F, et al. Predictors of morbidity following free flap reconstruction for cancer of the head and neck. Head Neck 2007; 29: 1090-1109.
11. Little JP,. Consistency of ASA grading. Anaesthesia 1995; 50; 658-659.
12. Haynes SR, Lawler PG,. An assessment of the consistency of ASA physical status classification allocation. Anaesthesia 1995: 50; 195-199.
13. Mangano DT, Layug EL, Wallace A, Tateo I,. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996; 335: 1713-1720.
14. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999; 341: 1789-1794.
15. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomized controlled trial. Lancet 2008; 371: 1839-1847.
16. Schouten O, Poldermans D, Visser L, et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. Am Heart J 2004; 148: 1047-1052.
17. Dawood MM, Gupta DK, Southern J, Walia A, Atkinson JB, Eagle KA,. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol 1996; 57: 37-44.
18. Warltier DC, Pagel PS, Kersten JR,. Approaches to the prevention of perioperative myocardial ischemia. Anesthesiology 2000; 92: 253-259.
19. Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing non-cardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 2009; 249: 921-926.